尿道成形术后人工尿道括约肌手术长期结局的多中心分析
结果显示经尿道成形术组AUS因感染、侵蚀或机械故障需取出的比例为56.2%,显著高于非经尿道成形术组的23.5%(P < .001)。
要点
- 经尿道成形术后AUS因感染、侵蚀或机械故障需取出的比例为56.2%,非经尿道成形术组为23.5%。
- 经尿道成形术技术与因侵蚀(P = .004)和萎缩(P = .008)导致的装置取出风险增加相关。
- 若预期后续需AUS,可考虑非经尿道成形术。
核心结论
- 经尿道成形术患者AUS并发症风险高于非经尿道成形术组。
- 若预期后续需AUS,非经尿道成形术可能更可取。
研究设计与样本
- 中位随访33.5个月(IQR 46)。
主要发现
- 经尿道成形术组AUS因感染、侵蚀和机械故障需取出的比例为56.2%,非经尿道成形术组为23.5%(P < .001)。
- 经尿道成形术技术与因侵蚀(P = .004)和萎缩(P = .008)导致的装置取出风险增加相关。
- 放疗(HR 0.46,95%CI 0.28-0.76,P = .002)、高血压(HR 0.44,95%CI 0.27-0.73,P = .0008)和患者年龄>68岁(HR 0.5,95%CI 0.3-0.81,P = .004)也与装置取出风险相关。
临床怎么用
- 对于尿道成形术后拟行AUS的患者,应评估既往尿道成形术式(经尿道 vs 非经尿道)。
- 若预期后续需AUS,优先考虑非经尿道成形术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The artificial urinary sphincter (AUS) is the gold standard for male stress urinary incontinence. There is limited and conflicting evidence examining outcomes in AUS insertion after urethroplasty, particularly whether and how urethroplasty techniques affect them. We evaluated complications of AUS insertion after urethroplasty in a multi-institutional cohort. We hypothesize that complications occur at higher rates and vary between transecting and nontransecting urethroplasty. MATERIALS AND METHODS: We retrospectively reviewed patients who underwent AUS after urethroplasty at 15 institutions. Demographic and clinical variables were analyzed. Urethroplasties were categorized as transecting or nontransecting. Long-term complications included AUS infection, erosion, and mechanical failure. RESULTS: One hundred seventy-eight cases were identified performed by 17 surgeons (range 4-40) from 15 institutions with a median follow-up of 33.5 (IQR 46) months. AUS complications requiring explantation, including infection, erosion, and mechanical failure after transecting urethroplasty, occurred in 56.2% compared with 23.5% after nontransecting urethroplasty (P < .001). Transecting urethroplasty technique was correlated with increased risk of device explant both from erosion (P = .004) and atrophy (P = .008). Radiation (HR, 0.46, 95% CI: 0.28-0.76, P = .002), hypertension (HR, 0.44, 95% CI: 0.27-0.73, P = .0008), and patient age (>68; HR, 0.5, 95% CI: 0.3-0.81, P = .004) also correlated to risk of device explantation. CONCLUSIONS: Risk of experiencing AUS complications is higher in patients with transecting urethroplasty compared with the nontransecting group. Nontransecting urethroplasty may be advisable if a subsequent need for AUS is anticipated.
引用
- Davis MF, Nikolavsky D, Cavalcanti AG, et al. Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery After Urethroplasty. J Urol. 2025. PMID: 41022035. doi:10.1097/JU.0000000000004794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。